Compare Quest Diagnostics Inc (DGX) vs United Airlines Holdings Inc (UAL) Price & Performance

Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.

DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.

United Airlines (UAL) trades at $107.44, down 2.48% on the day, with a bearish technical signal but strong fundamentals. The stock shows attractive valuation metrics including a P/E of 10.06 and P/S of 0.56, with consistent earnings beats in recent quarters. Recent news highlights aggressive customer acquisition strategies targeting competitors' premium travelers through status-match offers and Starlink WiFi partnerships.

UAL presents a value opportunity with Wall Street consensus at Buy and a $158.10 price target, though near-term headwinds include rising fuel costs and technical bearishness. The company's improving debt profile and sustained profitability support long-term upside, but investors face volatility from operational challenges and competitive pressures.